Skip to main content
. 2019 Jan 9;155(2):158–165. doi: 10.1001/jamadermatol.2018.4390

Table 2. Diagnostic Performance of Direct Immunofluorescence for Bullous and Nonbullous Pemphigoid, by Biopsy Sitea.

Biopsy Site No. % (95% CI) Likelihood Ratio (95% CI) Diagnostic OR (95% CI)
Sensitivity Specificity PPV NPV Positive Negative
Total Group
Healthy skin 480 80.7
(73.5-86.5)
99.1
(97.3-99.8)
97.7
(93.1-99.2)
91.5
(88.6-93.7)
87.4
(28.3-270.2)
0.2
(0.1-0.3)
447.2
(134.1-1491.8)
Perilesional skin 629 90.4
(85.7-93.9)
99.8
(98.7-100.0)
99.5
(96.5-99.9)
95.1
(92.9-96.7)
371.4
(52.4-2631.7)
0.1
(0.1-0.2)
3846.2
(513.7-28 800.4)
Lesional skin 373 76.2
(65.7-84.8)
99.7
(98.1-100.0)
98.5
(90.0-99.8)
93.5
(90.8-95.5)
220.2
(31.0-1563.6)
0.2
(0.1-0.4)
921.6
(121.5-6993.2)
Participants Without Skin Blisters
Healthy skin 253 74.5
(59.7-86.1)
99.0
(96.5-99.9)
94.6
(81.4-98.6)
94.4
(91.3-96.5)
76.7
(19.1-307.7)
0.3
(0.2-0.4)
297.5
(63.8-1386.8)
Perilesional skin 281 78.1
(62.4-89.4)
99.6
(97.7-100.0)
97.0
(81.8-99.6)
96.4
(93.7-97.9)
187.3
(26.3-1333.3)
0.2
(0.1-0.4)
849.7
(104.2-6930.5)
Lesional skin 254 68.4
(51.4-82.5)
99.5
(97.5-100.0)
96.3
(78.4-99.5)
94.7
(91.8-96.6)
147.8
(20.7-1057.0)
0.3
(0.2-0.5)
465.8
(58.2-3729.6)

Abbreviations: NPV, negative predictive value; OR, odds ratio; PPV, positive predictive value.

a

Participants may have had biopsy specimens for DIF from different biopsy sites (1482 biopsy specimens were analyzed in 1125 patients).